Improved epicardial cardiac fibroblast generation from iPSCs

J Mol Cell Cardiol. 2022 Mar:164:58-68. doi: 10.1016/j.yjmcc.2021.11.011. Epub 2021 Nov 24.

Abstract

Since the initial isolation of human embryonic stem cells and subsequent discovery of reprogramming methods for somatic cells, thousands of protocols have been developed to create each of the hundreds of cell types found in-vivo with significant focus on disease-prone systems, e.g., cardiovascular. Robust protocols exist for many of these cell types, except for cardiac fibroblasts (CF). Very recently, several competing methods have been developed to generate these cells through a developmentally conserved epicardial pathway. Such methods generate epicardial cells, but here we report that prolonged exposure to growth factors such as bFGF induces fibroblast spindle-like morphology and similar chromatin architecture to primary CFs. Media conditions for growth and assays are provided, as well as suggestions for seeding densities and timepoints for protein harvest of extracellular matrix. We demonstrate marker expression and matrix competency of resultant cells as shown next to primary human cardiac fibroblasts. These methods provide additional guidance to the original protocol and result in an increasingly stable phenotype.

Keywords: ATAC-sequencing; Cardiac fibroblast; Differentiation; Epicardial; iPSC.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Cell Differentiation
  • Cells, Cultured
  • Cellular Reprogramming
  • Chromatin / metabolism
  • Fibroblasts / metabolism
  • Heart
  • Human Embryonic Stem Cells*
  • Humans
  • Induced Pluripotent Stem Cells* / metabolism

Substances

  • Chromatin